Despite indications of renewed public attention to the rising cost of prescription drugs, Congress has actually paid little attention to and spent scant time on this issue in recent years. That much was clear when we examined data on congressional attention to prescription drugs, in the form of bill introductions during the period 1993-2015.
Read Full Article »
